The Power of 3 - How M3 Unifies Global Comms, Business Intelligence Research and Global Research
09 Oct 2023
Preview
Source: FiercePharma
None
M3: Delivering the power of 3 for Medicine, Media, Metamorphosis
Rapid developments in medical science have meant that people are living longer than ever before. With an increasingly ageing population, HCPs are under pressure to ensure their patients can maintain quality of life for as long as possible.
To achieve this, HCPs often rely on pharmaceutical companies to keep on top of new developments, latest news and clinical trials. As medical interventions can have a massive impact on a patient’s welfare, pharma companies have a responsibility to ensure that HCPs stay up-to-date with the latest health-related information.
When Tak Matsuoka, Managing Director of M3 (EU) Ltd entered the industry, one of the first things he quickly came to understand was that doctors are people first and they, like everyone else, do not have perfect knowledge. As a result, he believes that, “Many potentially life-threatening rare diseases, which are treatable if they are diagnosed early enough, are easily overlooked or misdiagnosed due to a knowledge gap.”
Technology is playing a huge role in bridging this gap and ensuring that HCPs, pharma and patients are all aligned. To help save as many lives as possible, M3 is passionate about achieving effective medical communication and increased knowledge sharing.
About M3
M3, aptly named for Medicine, Media, Metamorphosis, is a leading global provider of digital solutions in the medical communication field. In the fast-changing world of medicine, the company is passionate about driving excellence to achieve outstanding patient outcomes. Initially founded by an investment from Sony Corporation, over the last two decades M3 has achieved growth worldwide through acquisition of best-in-market companies and expansion of services. The company has offices around the globe, including Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul., to name a few, and has a global annual revenue of $1.7 billion.
M3’s core culture is focused on three action agendas: 1. Be obsessed with clients and quality of work; 2. Embody a CEO mentality – everyone in the company is important enough to be able to effect positive change and come up with new ideas; and 3. Be respectful to those you work with. The company has enjoyed continued growth and is thriving, with recent achievements including ranking number six on Forbes’ ‘most innovative growth company’ list in 2018, placed on Forbes’ Asia ‘best over a billion’ list the following year, and, in 2020, was ranked on Forbes’ global list of the world’s largest public companies.
The company’s mission is to use technology to help people live longer, healthier lives and reduce costs in healthcare. To achieve this, the company ensures their three elements - their communication team, their business intelligence research team and their global research team for doctors - work collaboratively.
Communications Team - Global Reach, Local Insight, Driven by Innovation.
Delivering marketing communications campaigns which are adapted at a local level delivers unparalleled results for our clients. To allow global clients to engage with doctors of all specialities in a uniquely meaningful and measurable way, campaigns are customised, translated and disseminated to doctors in each target market. Having a thorough understanding of target audiences, enables M3 to tailor their content to achieve the maximum return on investment and engagement.
“What that means is that the content we provide is not only fit-for-purpose from our perspective, from the healthcare professional perspective, but it's also fit-for-purpose and aligned with what the market is trying to do beyond global reach.” - Tim Russell Executive Vice President - M3 EU.
Business Intelligence Research Team (medeConnect)
medeConnect is M3’s full-service market research agency, and a leading provider of solution-focused research. It has more than 15 years of experience conducting primary research with doctors, nurses, pharmacists, patients, KOLs, payors, and other members of the health ecosystem.
medeConnect uses both qualitative and quantitative methodologies to deliver actionable, timely, and in-depth insights. Whether it is to source and conduct in-depth KOL interviews, or design and execute longitudinal multi-market quantitative trackers, it remains the expert partner of choice for dozens of clients worldwide.
In addition, medeConnect prides itself on being a keenly client-centric organisation, with particular focus on making the research journey as easy and hassle-free as possible for clients. As a recent client said: “I could not have wished for a better service on these rather complicated projects”.
Global Research Team for Doctors
M3 Global Research reaches respondents in 248 markets across 70 countries worldwide, providing them with data collection, support services, and market research recruitment.
Through the work carried out by M3 Global Research, HCPs are able to gain knowledge and expert opinions from doctors and other professionals within the healthcare industry on the services and products that are being marketed now and in the future.
The Bridge between Pharma and HCPs
As the marketplace is highly critical and competitive, it's essential that all new products and services are safe and relevant in order to be successful. This is why it is vital that M3 - who are recognised around the globe for providing thorough research on new innovations - continue to work collaboratively and efficiently to ensure the best possible outcomes for HCPs and their patients.
Without a doubt, technology and digital transformation will be changing the face of healthcare at unprecedented rates. M3 provides the bridge between doctors and pharma with the ethos of creating connections and improving healthcare for all.
Reach out to M3 on reachdoctors@eu.m3.com
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.